SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 368 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,074,970 | +1.1% | 561,582 | -4.5% | 0.02% | +4.3% |
| Q2 2023 | $67,339,020 | +91903.3% | 588,011 | +10.7% | 0.02% | -14.8% |
| Q1 2023 | $73,192 | +61.5% | 531,029 | +51.9% | 0.03% | +50.0% |
| Q4 2022 | $45,307 | -99.9% | 349,649 | +7.0% | 0.02% | +20.0% |
| Q3 2022 | $36,132,000 | +50.8% | 326,869 | +2.3% | 0.02% | +66.7% |
| Q2 2022 | $23,953,000 | -5.3% | 319,543 | +2.3% | 0.01% | +12.5% |
| Q1 2022 | $25,286,000 | -21.2% | 312,292 | -12.4% | 0.01% | -11.1% |
| Q4 2021 | $32,097,000 | -16.7% | 356,434 | -14.5% | 0.01% | -25.0% |
| Q3 2021 | $38,549,000 | +9.4% | 416,834 | -8.1% | 0.01% | +9.1% |
| Q2 2021 | $35,241,000 | +24.1% | 453,334 | +19.0% | 0.01% | +22.2% |
| Q1 2021 | $28,395,000 | -66.5% | 380,993 | -23.4% | 0.01% | -69.0% |
| Q4 2020 | $84,840,000 | +38.0% | 497,627 | +13.7% | 0.03% | +20.8% |
| Q3 2020 | $61,488,000 | -8.1% | 437,852 | +4.9% | 0.02% | -11.1% |
| Q2 2020 | $66,929,000 | +103.5% | 417,422 | +24.1% | 0.03% | +68.8% |
| Q1 2020 | $32,892,000 | -12.2% | 336,242 | +15.8% | 0.02% | +14.3% |
| Q4 2019 | $37,474,000 | +73.5% | 290,404 | +1.3% | 0.01% | +55.6% |
| Q3 2019 | $21,595,000 | -54.2% | 286,716 | -7.6% | 0.01% | -52.6% |
| Q2 2019 | $47,131,000 | +1397.2% | 310,174 | +1074.5% | 0.02% | +11.8% |
| Q1 2019 | $3,148,000 | +1000.7% | 26,408 | +583.1% | 0.02% | +750.0% |
| Q1 2018 | $286,000 | -74.9% | 3,866 | -81.1% | 0.00% | -71.4% |
| Q4 2017 | $1,139,000 | -17.6% | 20,463 | -32.9% | 0.01% | -22.2% |
| Q3 2017 | $1,382,000 | +28.9% | 30,477 | -4.2% | 0.01% | +28.6% |
| Q2 2017 | $1,072,000 | +26.7% | 31,815 | +11.3% | 0.01% | +40.0% |
| Q1 2017 | $846,000 | +66.2% | 28,589 | +54.2% | 0.01% | +66.7% |
| Q4 2016 | $509,000 | -53.8% | 18,541 | +3.4% | 0.00% | -50.0% |
| Q3 2016 | $1,101,000 | – | 17,927 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |